Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (11-20 of 1,352) with videos related to

Pageof 136
Sort By:
Ejhaem|December 5, 2022
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) DatabaseArleigh McCurdy, Martha Louzada, Christopher P Venner, et al.
Ejhaem|December 5, 2022
Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemiaChristopher Gerard Mullen, Victoria Louise Campbell, Tamasin Doig, et al.
Ejhaem|December 5, 2022
Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variantFieke W Hoff, Ti'ara L Griffen, Yihua Qiu, et al.
Ejhaem|December 5, 2022
A new aberrantly spliced <i>BCR-ABL1</i> transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemiaNicole Naumann, Ulrike Bross-Bach, Wolfgang Seifarth, et al.
Ejhaem|December 5, 2022
Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamideAbhinav Mathur, Joakim Edman, Livia Liang, et al.
Ejhaem|December 5, 2022
Lower-risk myelodysplastic syndromes: Current treatment options for anemiaMathieu Meunier, Sophie Park
Ejhaem|December 5, 2022
Systemic and medullary blastic plasmacytoid dendritic cell invasionChea Mathias, Brun Sophie, Loyens Maxime
Ejhaem|December 5, 2022
Seemingly trivial lesion with devastating consequencesEdwin Uriel Suárez M, Paula Villalba-Cuesta, Teresa Arquero, et al.
Ejhaem|December 5, 2022
HemoScreen hematology analyzer compared to Sysmex XN for complete blood count, white blood cell differential, and detection of leukocyte abnormalitiesAnna-Maria Linko-Parvinen, Kristiina Keränen, Kaisa Kurvinen, et al.
Ejhaem|December 5, 2022
Higher <i>RUNX1</i> expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patientsYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Pageof 136

Showing results (11-20 of 1,352) with videos related to

Sort By:
Pageof 136
Ejhaem|December 5, 2022
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) DatabaseArleigh McCurdy, Martha Louzada, Christopher P Venner, et al.
Ejhaem|December 5, 2022
Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemiaChristopher Gerard Mullen, Victoria Louise Campbell, Tamasin Doig, et al.
Ejhaem|December 5, 2022
Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variantFieke W Hoff, Ti'ara L Griffen, Yihua Qiu, et al.
Ejhaem|December 5, 2022
A new aberrantly spliced <i>BCR-ABL1</i> transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemiaNicole Naumann, Ulrike Bross-Bach, Wolfgang Seifarth, et al.
Ejhaem|December 5, 2022
Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamideAbhinav Mathur, Joakim Edman, Livia Liang, et al.
Ejhaem|December 5, 2022
Lower-risk myelodysplastic syndromes: Current treatment options for anemiaMathieu Meunier, Sophie Park
Ejhaem|December 5, 2022
Systemic and medullary blastic plasmacytoid dendritic cell invasionChea Mathias, Brun Sophie, Loyens Maxime
Ejhaem|December 5, 2022
Seemingly trivial lesion with devastating consequencesEdwin Uriel Suárez M, Paula Villalba-Cuesta, Teresa Arquero, et al.
Ejhaem|December 5, 2022
HemoScreen hematology analyzer compared to Sysmex XN for complete blood count, white blood cell differential, and detection of leukocyte abnormalitiesAnna-Maria Linko-Parvinen, Kristiina Keränen, Kaisa Kurvinen, et al.
Ejhaem|December 5, 2022
Higher <i>RUNX1</i> expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patientsYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Pageof 136